Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines

Cell-based molecular transport simulations are being developed to facilitate exploratory cheminformatic analysis of virtual libraries of small drug-like molecules. For this purpose, mathematical models of single cells are built from equations capturing the transport of small molecules across membranes. In turn, physicochemical properties of small molecules can be used as input to simulate intracellular drug distribution, through time. Here, with mathematical equations and biological parameters adjusted so as to mimic a leukocyte in the blood, simulations were performed to analyze steady state, relative accumulation of small molecules in lysosomes, mitochondria, and cytosol of this target cell, in the presence of a homogenous extracellular drug concentration. Similarly, with equations and parameters set to mimic an intestinal epithelial cell, simulations were also performed to analyze steady state, relative distribution and transcellular permeability in this non-target cell, in the presence of an apical-to-basolateral concentration gradient. With a test set of ninety-nine monobasic amines gathered from the scientific literature, simulation results helped analyze relationships between the chemical diversity of these molecules and their intracellular distributions.

[1]  Zhiyang Zhao,et al.  Lysosomes Contribute to Anomalous Pharmacokinetic Behavior of Melanocortin-4 Receptor Agonists , 2007, Pharmaceutical Research.

[2]  E. Jacotot,et al.  Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis. , 2006, Biochimica et biophysica acta.

[3]  M. Klempner,et al.  Lysosomotropic behavior of adrenergic antagonists in interactions with human neutrophils. , 1988, Biochemical pharmacology.

[4]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[5]  P. Ros,et al.  Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. , 1995, Chest.

[6]  Volkmar Weissig,et al.  Gene Therapy of the Other Genome: The Challenges of Treating Mitochondrial DNA Defects , 2007, Pharmaceutical Research.

[7]  V. Torchilin,et al.  Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy. , 2000, Current pharmaceutical biotechnology.

[8]  B. Müller,et al.  Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption , 1999, Pharmaceutical Research.

[9]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[10]  Muralikrishna Duvvuri,et al.  Weak Base Permeability Characteristics Influence the Intracellular Sequestration Site in the Multidrug-resistant Human Leukemic Cell Line HL-60* , 2004, Journal of Biological Chemistry.

[11]  Wataru Toriumi,et al.  Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. , 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  B. Blagg,et al.  A new approach for enhancing differential selectivity of drugs to cancer cells. , 2006, ACS chemical biology.

[13]  R. Lüllmann-Rauch,et al.  Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[14]  A. Chadli THE CANCER CELL , 1924, La Presse medicale.

[15]  Sanford M. Simon,et al.  Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Tong Zhao,et al.  The Role of the VPS4A-Exosome Pathway in the Intrinsic Egress Route of a DNA-Binding Anticancer Drug , 2006, Pharmaceutical Research.

[17]  F S Fay,et al.  Imaging in five dimensions: time-dependent membrane potentials in individual mitochondria. , 1993, Biophysical journal.

[18]  Stefan Trapp,et al.  Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[19]  R F Murphy,et al.  Assay of vacuolar pH in yeast and identification of acidification-defective mutants. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Tracey,et al.  3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. , 2003, The Biochemical journal.

[21]  Maria M. Posada,et al.  Rapid Doxorubicin Efflux from the Nucleus of Drug-Resistant Cancer Cells Following Extracellular Drug Clearance , 2007, Pharmaceutical Research.

[22]  Muralikrishna Duvvuri,et al.  A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition , 2004, Pharmaceutical Research.

[23]  M. Brand,et al.  Factors determining the plasma-membrane potential of lymphocytes. , 1982, The Biochemical journal.

[24]  Qian Li,et al.  PROSPECTING FOR LIVE CELL BIOIMAGING PROBES WITH CHEMINFORMATIC ASSISTED IMAGE ARRAY (CAIA) , 2007, 2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[25]  S. Chong,et al.  Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.

[26]  Kerby Shedden,et al.  Chemoinformatic Analysis of a Supertargeted Combinatorial Library of Styryl Molecules , 2003, J. Chem. Inf. Comput. Sci..

[27]  B Poole,et al.  Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances , 1981, The Journal of cell biology.

[28]  Peter Schneider,et al.  Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes , 2006, Archives of Toxicology.

[29]  I. Forgacs GASTROENTEROLOGY , 1988, The Lancet.

[30]  A. Yamamoto,et al.  Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells 1 , 2003, The Journal of Immunology.

[31]  Jan Kelder,et al.  Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines. , 2004, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[32]  G. Rosania,et al.  Supertargeted chemistry: identifying relationships between molecular structures and their sub-cellular distribution. , 2003, Current topics in medicinal chemistry.

[33]  Jae Wook Lee,et al.  Combinatorial approach to organelle-targeted fluorescent library based on the styryl scaffold. , 2003, Journal of the American Chemical Society.

[34]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[35]  R F Murphy,et al.  A chloroquine-resistant Swiss 3T3 cell line with a defect in late endocytic acidification , 1988, The Journal of cell biology.

[36]  M Bichara,et al.  Perhexiline maleate-induced cirrhosis. , 1979, Gastroenterology.

[37]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[38]  Muralikrishna Duvvuri,et al.  A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. , 2005, Molecular pharmaceutics.

[39]  W. Daniel,et al.  Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping , 2001, British journal of pharmacology.

[40]  R. C.-Gaudreault,et al.  Massive Cell Vacuolization Induced by Organic Amines Such as Procainamide , 2004, Journal of Pharmacology and Experimental Therapeutics.

[41]  R. Horobin,et al.  A predictive model for the selective accumulation of chemicals in tumor cells , 2005, European Biophysics Journal.

[42]  Kerby Shedden,et al.  A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. , 2006, Molecular pharmaceutics.

[43]  C. Pomerat,et al.  MECHANISM OF DRUG-INDUCED VACUOLIZATION IN TISSUE CULTURE. , 1965, Experimental cell research.

[44]  A. Roscher,et al.  Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. , 1983, The Journal of pharmacology and experimental therapeutics.

[45]  Mark J. Reasor,et al.  Drug-Induced Phospholipidosis: Are There Functional Consequences? , 2001, Experimental biology and medicine.

[46]  J. Falgueyret,et al.  Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99. , 2004, Analytical biochemistry.

[47]  Vladimir P Torchilin,et al.  DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Kerby Shedden,et al.  System dynamics of subcellular transport. , 2004, Molecular pharmaceutics.

[49]  Kevin Steffy,et al.  Masked oral prodrugs of toll-like receptor 7 agonists: a new approach for the treatment of infectious disease. , 2006, Current opinion in investigational drugs.

[50]  P Donatsch,et al.  Effects of cyproheptadine on the rat yolk sac membrane and embryonic development in vitro. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[51]  K. Yokogawa,et al.  Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs. , 2000, The Journal of pharmacology and experimental therapeutics.

[52]  R. C.-Gaudreault,et al.  N-Substituted 4-Aminobenzamides (Procainamide Analogs): An Assessment of Multiple Cellular Effects Concerning Ion Trapping , 2005, Molecular Pharmacology.

[53]  Emi Nakashima,et al.  Contribution of Lysosomes to the Subcellular Distribution of Basic Drugs in the Rat Liver , 2004, Pharmaceutical Research.

[54]  A. Bulychev,et al.  Uptake and intracellular distribution of neutral red in cultured fibroblasts. , 1978, Experimental cell research.

[55]  J. Tolan,et al.  MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.

[56]  R. W. Van Dyke,et al.  Proton pump-generated electrochemical gradients in rat liver multivesicular bodies. Quantitation and effects of chloride. , 1988 .

[57]  Jeffrey P Krise,et al.  Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. , 2007, Journal of pharmaceutical sciences.

[58]  C M McCloud,et al.  In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages. , 1995, Experimental and molecular pathology.

[59]  P. Seglen,et al.  Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes. , 1980, Molecular pharmacology.

[60]  Leszek Kaczmarek,et al.  Increased Expression of Cathepsin D in Retrosplenial Cortex of MK-801-Treated Rats , 1997, Experimental Neurology.

[61]  R F Murphy,et al.  Primary cell cultures from murine kidney and heart differ in endosomal pH , 1998, Journal of cellular physiology.

[62]  C. Slapak,et al.  Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. , 1997, Blood.

[63]  J. Falgueyret,et al.  Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity. , 2005, Journal of medicinal chemistry.

[64]  H. Ginsburg,et al.  Effects of lysosomotropic detergents on the human malarial parasite Plasmodium falciparum in in vitro culture. , 1989, Biochemical pharmacology.

[65]  W. Bretz,et al.  Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.

[66]  G. Cramb,et al.  Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. , 1986, Biochemical pharmacology.

[67]  G. Quack,et al.  Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission. , 1993, Pharmacology & toxicology.

[68]  Luca Scorrano,et al.  A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. , 2002, Cancer cell.

[69]  Amol D. Kulkarni,et al.  Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria , 2007, Clinical Cancer Research.